NEW DELHI, Jan. 15 -- The government is yet to decide on providing indemnity to Serum Institute of India (SII) and Bharat Biotech International, and the purchase pacts with the two vaccine makers do not include the provision, three people aware of the development said.
Both Serum Institute and Bharat Biotech had requested indemnity in case there are health complications after the vaccination. An indemnity is a form of insurance for legal claims made by vaccine beneficiaries if they have serious adverse events after receiving a dose. If the indemnity is granted, the government will be liable to pay compensation to the affected people.
"We have discussed indemnity with several companies, including Serum and Bharat Biotech, and also the regu...